Skip to content
AI IntelligenceJun 27, 2026Primary Market
Article

Vance AI · $90M · Series A

Vance AI, a biotech AI startup, closed a Series A round. The company uses machine learning for drug discovery, accelerating the development of new therapies.

Data Cube AI EditorialSource: Crunchbase News
01

Source Brief

Vance AI, a biotech AI startup, closed a Series A round. The company uses machine learning for drug discovery, accelerating the development of new therapies.